Type | Public | |
Founded | 1992 | |
HQ | Boston, MA, US | Map |
Website | alexion.com |
USD | |
---|---|
Revenue (FY, 2020) | 6.1b |
Gross profit (FY, 2020) | 5.5b |
Gross profit margin (FY, 2020), % | 90.9% |
Net income (FY, 2020) | 603.4m |
EBIT (FY, 2020) | 632.3m |
Market capitalization (26-Feb-2021) | 33.6b |
Closing stock price (26-Feb-2021) | 152.8 |
Cash (31-Dec-2020) | 3.0b |
EV | 33.4b |
USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 541.0m | 783.4m | 1.1b | 1.6b | 2.2b | 2.6b | 3.1b | 3.6b | 4.1b | 5.0b | 6.1b |
Revenue growth, % | 44% | 17% | 18% | ||||||||
Cost of goods sold | 64.4m | 93.1m | 72.8m | 177.6m | 173.9m | 233.1m | 258.0m | 454.2m | 374.3m | 394.5m | 553.5m |
Gross profit | 476.5m | 690.3m | 1.1b | 1.4b | 2.1b | 2.4b | 2.8b | 3.1b | 3.8b | 4.6b | 5.5b |
USD | Q2, 2010 | Q3, 2010 | Q1, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 125.8m | 141.6m | 166.1m | 204.0m | 244.7m | 274.7m | 294.1m | 338.9m | 370.1m | 400.4m | 566.6m | 512.5m | 555.1m | 600.3m | 636.2m | 666.6m | 701.0m | 753.1m | 799.1m | 870.0m | 912.0m | 859.0m | 930.9m | 1.0b | 1.0b | 1.1b | 1.2b | 1.3b | 1.4b | 1.4b |
Cost of goods sold | 13.7m | 16.5m | 19.2m | 23.4m | 28.3m | 31.6m | 20.2m | 35.3m | 39.4m | 51.4m | 32.9m | 39.6m | 51.9m | 69.4m | 52.0m | 54.1m | 59.0m | 60.6m | 71.1m | 69.0m | 84.0m | 157.0m | 91.6m | 95.3m | 90.6m | 85.8m | 99.2m | 95.2m | 111.7m | |
Gross profit | 112.1m | 125.1m | 146.9m | 180.7m | 216.5m | 243.1m | 273.9m | 303.7m | 330.7m | 349.0m | 533.7m | 472.9m | 503.3m | 530.9m | 584.2m | 612.6m | 642.1m | 692.5m | 728.0m | 801.0m | 828.0m | 702.0m | 839.3m | 949.7m | 935.9m | 1.1b | 1.1b | 1.2b | 1.3b | |
Gross profit Margin, % | 89% | 88% | 88% | 89% | 88% | 88% | 93% | 90% | 89% | 87% | 94% | 92% | 91% | 88% | 92% | 92% | 92% | 92% | 91% | 92% | 91% | 82% | 90% | 91% | 91% | 92% | 92% | 92% | 92% |
USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 267.1m | 540.9m | 989.5m | 529.9m | 944.0m | 1.0b | 966.0m | 584.4m | 1.4b | 2.7b | 3.0b |
Accounts Receivable | 168.7m | 244.3m | 295.6m | 421.8m | 432.9m | 532.8m | 650.0m | 726.5m | 922.3m | 1.2b | 1.4b |
Prepaid Expenses | 26.9m | 50.8m | 75.3m | 87.3m | 189.4m | 217.6m | 292.9m | 426.4m | 456.1m | ||
Inventories | 62.2m | 81.4m | 94.5m | 102.6m | 176.4m | 289.9m | 375.0m | 460.4m | 472.5m | 627.6m |
USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 97.0m | 175.3m | 254.8m | 252.9m | 656.9m | 144.4m | 399.0m | 443.3m | 77.6m | 2.4b | 603.4m |
Depreciation and Amortization | 15.8m | 17.6m | 23.9m | 28.7m | 46.9m | 166.6m | 396.0m | 496.7m | 405.3m | 376.8m | 329.4m |
Inventories | (14.1m) | (12.2m) | (6.3m) | 126.0k | (66.8m) | (88.4m) | (84.0m) | (88.2m) | (14.7m) | (156.9m) | |
Accounts Payable | 47.5m | 79.8m | 61.7m | 136.6m | 264.6m | (115.9m) | 150.0m | (55.1m) | 230.7m | 122.5m |
USD | Q2, 2010 |
---|---|
Financial Leverage | 1.1 x |
Company Name | Date | Deal Size |
---|---|---|
Syntimmune | September 26, 2018 | $1.20 b |
Alexion Pharmaceuticals has 10.15k Twitter Followers. The number of followers has increased 9.4% month over month and increased 32.1% quarter over quarter
1.1k
Tweets
321
Following
10.1k
Followers
27
Tweets last 30 days
29.1
Avg. likes per Tweet
100%
Tweets with engagement
When was Alexion Pharmaceuticals founded?
Alexion Pharmaceuticals was founded in 1992.
Who are Alexion Pharmaceuticals key executives?
Alexion Pharmaceuticals's key executives are Ludwig Hantson, Tanisha Carino and John Orloff.
How many employees does Alexion Pharmaceuticals have?
Alexion Pharmaceuticals has 3,082 employees.
What is Alexion Pharmaceuticals revenue?
Latest Alexion Pharmaceuticals annual revenue is $6.1 b.
What is Alexion Pharmaceuticals revenue per employee?
Latest Alexion Pharmaceuticals revenue per employee is $2 m.
Who are Alexion Pharmaceuticals competitors?
Competitors of Alexion Pharmaceuticals include Regeneron Pharmaceuticals, Aravive and Deciphera Pharmaceuticals.
Where is Alexion Pharmaceuticals headquarters?
Alexion Pharmaceuticals headquarters is located at 121 Seaport Blvd, Boston.
Where are Alexion Pharmaceuticals offices?
Alexion Pharmaceuticals has offices in Boston, Washington, Frenchs Forest, Elsene and in 18 other locations.
How many offices does Alexion Pharmaceuticals have?
Alexion Pharmaceuticals has 23 offices.
Receive alerts for 300+ data fields across thousands of companies